COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • Organization Diagram
    • Board of Directors
    • Research team
    • Scientific visitors
    • Location
    • Funding
    • Logo
    • Personal privacy policy
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Publications
    • Theses
    • Literature for parents
  • Research Projects
    • COPSYCH
    • EAGLE Consortium
    • EarlyVir
  • Strategy
    • Author guidelines
  • ‌

2004 Lotte Loland, MD, PhD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
Home Home Dissemination Theses 2004 Lotte Loland, MD, PhD

Lung Function in Infants

By Lotte Loland, MD, PhD

Summary

Chairman: Vibeke Backer

Opponent: Peter Oluf Schiøtz

Opponent: Bent Klug

(PDF)

This Ph.D. thesis is based on studies conducted during my employment at the Department of Pediatrics, Copenhagen University Hospital, Rigshospitalet. Respiratory diseases are a major cause of morbidity in infants; and lung function testing can provide information on the causes, pathophysiology and consequences of these diseases, as well as on effect of therapeutic intervention.
The aim of the thesis was to evaluate sensitivity, repeatability and feasibility of: measurements of tidal breathing, forced expirations by the raised volume rapid thoracic compression (RVRTC) technique, auscultation and measurements of transcutaneous oxygen (PtCO2) during a methacholine challenge test in infants.
These techniques reflect different aspects of lung function and pose considerably different resource requirements, including sedation.
PtCO2 was the most sensitive parameter for detecting changes in lung function, followed by forced expiratory volume in 0.5 second (FEV0.5) obtained by the RVRTC technique. Coefficients of variation for PtCO2: 4% and FEV0.5: 7%.
Feasibility was evaluated in terms of success rate, safety, acceptability and resource requirements. Baseline lung function was determined in 99% and 94%, and bronchial responsiveness in 87% and 88%, of the infants, by FEV0.5 and PtCO2 respectively. No safety issues of concern were observed and the response of the parents was favourable. A complete test, carried out by one operator, took three hours.
In conclusion, PtCO2 and FEV0.5 are the most sensitive parameters for detecting changes in infant lung function. Baseline measurements of FEV0.5 and measurements of bronchial responsiveness by PtCO2 would improve feasibility of future studies on lung function in infancy. The requirement of sedation restricts their use to research and selected clinical cases.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • Organization Diagram
    • Board of Directors
    • Research team
    • Scientific visitors
    • Location
    • Funding
    • Logo
    • Personal privacy policy
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Publications
    • Theses
    • Literature for parents
  • Research Projects
    • COPSYCH
    • EAGLE Consortium
    • EarlyVir
  • Strategy
    • Author guidelines
  • ‌
COPSAC